Council on the Kidney in Cardiovascular Disease (KCVD)

Message from the Chair

Welcome to the Council for the Kidney in Cardiovascular Disease (KCVD). Our Council strives to reduce cardiovascular-related disability and death through clinical, translational, and basic research, communication, advocacy and education relevant to: a) the role of the kidney in hypertension, b) the role of the kidney in cardiovascular diseases – this includes acute kidney injury and chronic kidney disease and its effects on heart disease, stroke, and peripheral vascular disease, c) the specific role of the kidney in diabetes-induced cardiovascular disease, and d) cardio-renal syndrome.

Alexander Staruschenko, PhD, FAHA
Chair, Council on Kidney in Cardiovascular Disease

Hypertension Scientific Sessions 2022

September 7–10, 2022
Hilton San Diego Bayfront | San Diego, CA
black male doctor

AHA Professional Members are Difference Makers

research

Funding Opportunities

The method for applying for funding is Web-based, using our electronic system, ProposalCentral.


Hypertension Journal cover

Hypertension

Hypertension is one of 11 AHA journals. It represents the Councils on HBPR and KCVD, in cooperation with the Inter-American Society of Hypertension.


Scientific Sessions 2022

Pre-Sessions Symposia & Early Career Day: November 4
Scientific Sessions: November 5–7
Chicago, IL + Virtual